Biotech
-
Ernexa Therapeutics Advances ERNA-101 to First-in-Human Trial Planning
SINGAPORE, July 15 — A new cancer therapy candidate is taking its first step from the laboratory bench toward the bedside, with…
-
Akeso gets FDA and China clearance for Phase II cadonilimab liver cancer trial
BEIJING, July 15 — Akeso’s experimental cancer drug cadonilimab is now being studied in a Phase II clinical trial in the United…
-
Akeso starts US Phase II cadonilimab trial in gastric cancer with Memorial Sloan Kettering
ISLAMABAD, July 15 — Akeso, the Chinese biopharmaceutical company, has advanced its investigational drug cadonilimab into a Phase II clinical trial in…
-
Model Finds DNA Mutations Alone Could Cap Median Human Lifespan at 146 to 194 Years
WASHINGTON, July 14 — The global race to slow human aging is no longer a fringe scientific pursuit; it is a strategic…
-
James Allison’s CTLA-4 Discovery Pioneered Cancer Checkpoint Therapy
HOUSTON, July 14 — The technical reality of cancer immunotherapy is that the body’s own T cells often have the means to…
-
HDT Bio Takes Glioblastoma Immunotherapy HDT-401 Toward a Phase 1 Trial at McGill
MONTREAL, July 13 — McGill University has announced a new partnership with HDT Bio, a biotechnology firm, to advance clinical trials for…
-
Chinese Biotech Deals With Big Pharma Surge as Drugmakers Face Patent Cliff
BEIJING, July 13 — Cross-border deals for innovative drugs originating from China have reached a record US$110 billion in the first half…
-
Katalin Karikó’s mRNA research wins 2023 Nobel Prize
LONDON, July 10 — The detail that matters in the story of Katalin Karikó is not the Nobel Prize, nor the 95%…
-
UCSF team reprograms T cells inside the body to clear cancer in mice
ISLAMABAD, July 10 — For patients and families facing blood cancers, the word “remission” carries a weight that is both fragile and…
-
CAR-T Sales in 2023: Gilead’s Yescarta Led at $1.5 Billion as Kymriah Slipped
ISLAMABAD, July 7 — The global market for CAR-T cell therapy, a personalized cancer treatment that reprograms a patient’s own immune cells…
-
Strand Life Sciences Wins Indian Patent for Blood-Based Early Cancer Detection Test
BANGALORE, July 7 — A new patented technology from Strand Life Sciences is changing how doctors look for cancer in its earliest,…
-
Global Oncology Precision Medicine Market Set for Robust Expansion Through 2031
GLOBAL — July 1, 2026 — The global market for oncology precision medicine is opening up fresh opportunities in diagnostics and therapeutics,…
-
Zelluna Secures NOK 16 Million Grant for TCR-NK Research
OSLO, June 30 — Zelluna ASA, a company listed on the Oslo Stock Exchange under the ticker ZLNA, has been awarded a…
-
Antarctic sea creature toxin shows melanoma-killing potential in mouse study
A toxin harvested from a tiny sea creature collected off Antarctica has killed melanoma in mice without harming the mice. That fact…
-
Anixa Biosciences Secures First Korean Patent for Breast Cancer Vaccine
Anixa’s Korean Patent Opens Door to Clinical Trials in Asia SAN JOSE — The patent paperwork is done. Now comes the hard…
-
Health Systems Invest in Cadence’s $100M Remote Patient Monitoring Platform
Health systems are putting real money behind remote patient monitoring. That is the headline from Cadence’s $100 million Series C raise, led…
-
FDA Clears First Human Trial of Partial Epigenetic Reprogramming for Eye Disease
BOSTON, June 11 — Life Biosciences, a Boston-based longevity company, has started the first FDA-approved human clinical trial to turn back time…
-
New Drug Targets ‘Undruggable’ KRAS in Pancreatic Cancer
For many years the KRAS gene was regarded as an impossible target for drug development. Its surface lacks distinct pockets, giving medicinal…
-
Abbott Buys Exact Sciences in $21B Cancer Deal
MADISON, Wis. — The stool DNA test sits in a box. Patients collect a sample at home, mail it to a lab,…
-
How the GLP-1 Hormone Works and Why It Became a Diabetes and Obesity Drug Target
A hormone first characterized in the 1980s has become the foundation of a major transformation in how physicians manage diabetes and obesity.…
-
EU Approves New Lymphoma Treatment Odronextamab for Patients
European patients with two forms of lymphoma now have access to a newly approved medication that works through a distinctive biological mechanism.…
-
Grail spin-out from Illumina completed June 2024 after EU regulatory order
June 29, 2024 — cyberinktimes.com — On June 24, 2024, a significant development occurred in the biotechnology sector as GRAIL, Inc., a…
-
FDA Approves Imetelstat for Treating Myelodysplastic Syndromes with Anemia
In a pivotal shift for the cancer treatment landscape, the US Food and Drug Administration (FDA) granted approval on June 15, 2024,…
-
Moderna’s KRAS Cancer Vaccine Candidate Was Dropped by Merck After Phase 1 Enrollment
In the realm of cancer research, the tetravalent vaccine candidate, code-named V941 or mRNA-5671, developed by Moderna, continues to garner attention within…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992